Medipharm Financial Statements From 2010 to 2024
| MEDIF Stock | USD 0.05 0 4.00% |
Check Medipharm Labs financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Medipharm Labs' main balance sheet or income statement drivers, such as , as well as many indicators such as . Medipharm financial statements analysis is a perfect complement when working with Medipharm Labs Valuation or Volatility modules.
Medipharm |
Medipharm Labs Corp OTC Stock Return On Asset Analysis
Medipharm Labs' Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Medipharm Labs Return On Asset | -0.24 |
Most of Medipharm Labs' fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Medipharm Labs Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Based on the latest financial disclosure, Medipharm Labs Corp has a Return On Asset of -0.236. This is 97.3% lower than that of the Healthcare sector and significantly lower than that of the Drug Manufacturers—Specialty & Generic industry. The return on asset for all United States stocks is 68.57% higher than that of the company.
Medipharm Labs Corp Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Medipharm Labs's current stock value. Our valuation model uses many indicators to compare Medipharm Labs value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Medipharm Labs competition to find correlations between indicators driving Medipharm Labs's intrinsic value. More Info.Medipharm Labs Corp is regarded third in return on equity category among its peers. It is regarded fourth in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Medipharm Labs' earnings, one of the primary drivers of an investment's value.About Medipharm Labs Financial Statements
Medipharm Labs stakeholders use historical fundamental indicators, such as Medipharm Labs' revenue or net income, to determine how well the company is positioned to perform in the future. Although Medipharm Labs investors may analyze each financial statement separately, they are all interrelated. For example, changes in Medipharm Labs' assets and liabilities are reflected in the revenues and expenses on Medipharm Labs' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Medipharm Labs Corp. Please read more on our technical analysis and fundamental analysis pages.
MediPharm Labs Corp., a pharmaceutical company, produces and sells pharmaceutical-quality cannabis oil and concentrates, and advanced derivative products in Canada, Australia, Germany, and internationally. MediPharm Labs Corp. was founded in 2015 and is headquartered in Barrie, Canada. MEDIPHARM LABS is traded on OTC Exchange in the United States.
Currently Active Assets on Macroaxis
Other Information on Investing in Medipharm OTC Stock
Medipharm Labs financial ratios help investors to determine whether Medipharm OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Medipharm with respect to the benefits of owning Medipharm Labs security.